Pelthos Therapeutics Inc. - 8-K Filing
Pelthos Therapeutics Inc. filed to disclose the dismissal of its independent registered public accounting firm, CBIZ CPAs P.C., effective May 18, 2026, and the appointment of Grant Thornton LLP as its new auditor for fiscal year ending December 31, 2026. The company also announced a separation agreement with former CFO Francis Knuettel II, including $430,000 in severance pay and accelerated vesting of equity awards. (Items: 4.01 Changes in Registrant’s Certifying Accountant, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmentof Certain Officers; Compensatory Arrangements of Certain Offic, 9.01 Financial Statements and Exhibits)
Tickers: $PTHS